<DOC>
	<DOCNO>NCT00370721</DOCNO>
	<brief_summary>To evaluate effect intravitreal bevacizumab course diabetic retinopathy case sign active progressive PDR</brief_summary>
	<brief_title>Intravitreal Bevacizumab Management Active Progressive Proliferative Diabetic Retinopathy ( PDR )</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Cases active progressive PDR history scatter laser photocoagulation history vitrectomy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Proliferative diabetic retinopathy ( PDR )</keyword>
	<keyword>Pan retinal photocoagulation ( PRP )</keyword>
	<keyword>Vitreous hemorrhage</keyword>
	<keyword>Traction retinal detachment</keyword>
	<keyword>Neovascularization disc ( NVD )</keyword>
	<keyword>Neovascularization elsewhere ( NVE )</keyword>
	<keyword>Fibrous proliferation disc ( FPD )</keyword>
	<keyword>Fibrous proliferaiton elsewhere ( FPE )</keyword>
</DOC>